FDA GUIDANCEJan 2024
New bioequivalence and skin irritation testing standards for transdermal patches.
Transdermal Drug Regulation Horizon (2020 - 2026)
AI monitors external FDA/EMA regulatory changes and cross-references with your Labfolder data.
Regulatory Feed
BfArM / EMA DIRECTIVESept 2025
Tightened manufacturing QA controls for semi-solid topical matrices.
AI Impact Assessment
FLAGGED RISK
3 files in your Labfolder '/Formulation_v3' folder use old testing protocols. Action required to align with Jan 2024 FDA standards.
AUTO-RESOLVED
Mismatched Labeling: Past chemist labeled synthesis run as 'Topical-Z'. AI matched this to the new EMA semi-solid matrix definition automatically.